Lumida
/PODD
⌘K
Insulet Corp

Insulet Corp

PODD
$131.96USD-2.02%-2.72 today

MARKET CAP

9.2B

P/E (TTM)

30.8x

FWD P/E

DAY RANGE

$131 – $136

52W RANGE

$126
$355

AI Summary

Stalk
Sell NowMedium

PODD remains in a Stage 4 decline with both medium- and long-term biases bearish. Price is extended below falling EMAs and near the 52-week low, with RSI deeply oversold but no exhaustion visible. Short-term rallies into the 9/21 EMA zone offer optimal sell entries, warranting immediate participation in the breakdown.

  • Q2 revenue $802M, +23% YoY (constant currency).
  • Adjusted EPS rose 41.5% to $1.66.
  • Negative earnings yield and low book-to-price ratio imply overvaluation.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$1.1B$1.3B$1.7B$2.1B$2.7B
YoY %+21.5%+18.8%+30.0%+22.1%+30.7%
P / Sales16.6x15.3x9.1x9.3x7.5x
EV / Sales17.2x16.2x9.8x9.8x7.9x
Gross Profit, Adj.$752.1M$805.6M$1.2B$1.4B$1.9B
YoY %+29.2%+7.1%+44.0%+24.6%+34.2%
Margin %68.4%61.7%68.3%69.8%71.6%
EV / Gross Profit25.2x26.2x14.3x14.0x11.0x
EBITDA, Adj.$183.4M$100.8M$292.9M$389.7M$564.2M
YoY %+71.6%-45.0%+190.6%+33.0%+44.8%
Margin %16.7%7.7%17.3%18.8%20.8%
EV / EBITDA103.3x209.5x56.5x51.9x37.9x
EBIT$126.0M$37.6M$220.1M$308.9M$473.8M
YoY %+144.7%-70.2%+485.4%+40.3%+53.4%
Margin %11.5%2.9%13.0%14.9%17.5%
EV / EBIT150.4x561.7x75.2x65.4x45.1x
Net Income$16.8M$4.6M$206.3M$418.3M$247.1M
YoY %+147.1%-72.6%+4384.8%+102.8%-40.9%
Net Margin1.5%0.4%12.2%20.2%9.1%
EPS (GAAP)$0.24$0.07$2.94$5.78$3.48
YoY %+140.0%-70.8%+4100.0%+96.6%-39.8%